Managing ADHD Across the Lifecycle
January 31, 2018
January 31, 2019
Scroll to the Bottom of this Information to Begin this Course
Jointly provided by Postgraduate Institute for Medicine and Global Medical Education.
Supported by independent educational grants from Allergan, Merck, Neurocrine Biosciences, Sage Therapeutics, Shire, and Sunovion.
- Physicians — maximum of 1.25 AMA PRA Category 1 Credit(s)™
- Pharmacists — 1.25 contact hour(s) (0.125 CEUs).
- Psychologists — 1.25 CE credits.
- Physician Assistants — 1.0 credits.
- Nurses — 1.2 contact hours (designated for 0.3 contact hours of pharmacotherapy credit for APRNs).
All other health care professionals completing this course will be issued a statement of participation.
These modules have been designed to meet the educational needs of physicians, physician assistants, nurse practitioners, registered nurses, pharmacists, and psychologists who care for patients with psychiatric disorders.
Upon completion of this activity, participants should be able to:
- Explain the latest advances in our understanding of ADHD across the lifespan.
- Develop individualized pharmacotherapy plans for patients with ADHD that take into account efficacy and safety, patient age, comorbidities, and dosing schedule needs.
- Recognize the role of evidence based psychotherapy as an adjunct.
- Discuss innovative treatments on the horizon.
Jeffery Newcorn, M.D.
Associate Professor of Psychiatry and Pediatrics
Icahn School of Medicine, Mount Sinai
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Global Medical Education. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1.25 contact hour(s) (0.125 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: JA4008162-9999-18-170-H01-P
Type of Activity: Application
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.2 contact hours. Designated for 0.3 contact hours of pharmacotherapy for Advance Practice Registered Nurses.
Psychologist Continuing Education
Postgraduate Institute for Medicine (PIM) is approved by the American Psychological Association to sponsor continuing education for psychologists. PIM maintains responsibility for this program and its content.
This program offers a maximum of 1.25 continuing education credits for psychologists.
Physician Assistant Continuing Education
The program has been reviewed and is approved for a maximum of 1.00 AAPA Category 1 CME credits by the AAPA Review Panel. Approval is valid for one year from the issue date of 02/15/2018. Participants may submit the post-test at any time during that period.
This program was planned in accordance with AAPA CME Standards for Enduring Material Programs and for Commercial Support of Enduring Material Programs.
Disclosures of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of these CME activities:
Jeffrey Newcorn, M.D.
- Consultant: Alcobra, Enzymotec, Ironshore, Neos, NFL, NLS, Sunovion
- Advisory Board: Akili Interactive, Alcobra, Arbor, KemPharm, Ironshore, Lundbeck,Medice, Pearson, Shire, Supernus
- Research Support: Enzymotec, Lundbeck, Shire
- Speaker’s Bureau: Shire
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Prakash Masand, MD (GME Manager)
- Consultant: Allergan, Lundbeck, Merck, Otsuka, Pfizer, Sunovion, Takeda.
- Research Support: Allergan, Merck.
- Speaker’s Bureau: Allergan, GlaxoSmithKline, Lundbeck, Merck, Otsuka, Pfizer, Sunovion, Takeda.
The following PIM planners and managers, Trace Hutchison, PharmD, Judi Smelker-Mitchek, RN, BSN, Samantha Mattiucci, PharmD, CHCP, and Jan Schultz, MSN, RN, CHCP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of these activities of any amount during the past 12 months.
Instructions for Participation and Credit
There are no fees for participating and receiving credit for this activity. During the period January 31, 2018 through January 31, 2019, participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity; and 3) complete the post-test and the evaluation form for each module completed
To answer the questions, click on your selected choice for each answer then proceed to the next question. We recommend that you print a copy of your answers before you submit them to us. Once completed, click on Submit Post-test at the bottom of the page. Your post-test will automatically be graded.
If you successfully complete the post-test (score of 75% or higher), your certificate will be made available immediately. Click on View Certificate and print the certificate for your records. If you receive a score of 74% or less, you will receive a message notifying you that you did not pass the post-test. You may retake the post-test until successful.
For Pharmacists: Upon successfully completing the post-test with a score of 75% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service.
Hardware and Software Requirements
Hardware and Software RequirementsCME University requires a modern web browser (Internet Explorer 7+, Mozilla Firefox, Apple Safari, Google Chrome). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple Quicktime, Adobe Acrobat, Microsoft Powerpoint, Windows Media Player, and Real Networks Real One Player. If in doubt, you may which to check your current browser at the independent, third party site: WhatsMyBrowser.org.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity does not recommend the use of any agent outside of the labeled indications.
The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in these activities should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.